4th Quarter - Report — DEXCOM, INC. for DEXCOM, INC. (2017)

Firm

DEXCOM, INC.

Client

DEXCOM, INC.

Income

—

Expenses

$7,651

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Current coverage policy for therapeutic continuous glucose monitoring systems

Lobbyist	Covered position, as disclosed
BRUCE THOMAS TAYLOR	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Coverage policy for therapeutic continuous glucose monitoring equipment

Lobbyist	Covered position, as disclosed
BRUCE THOMAS TAYLOR New	Carla DiBlasio

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.